Alzheimer's Disease Genetics Study (NCRAD)
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.
Late Onset Alzheimer Disease
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||National Cell Repository for Alzheimer's Disease (NCRAD)|
- Distribute biological specimens to qualified investigators for use in their research studies. [ Time Frame: Contact investigators annually for an update on progress and publication status. ] [ Designated as safety issue: No ]Investigators will analyze the samples and publish de-identified results. These publications will help to further the knowledge in the field of dementia and potentially lead to new therapies and targets for therapies.
Biospecimen Retention: Samples With DNA
|Study Start Date:||June 2002|
|Estimated Study Completion Date:||June 2016|
|Estimated Primary Completion Date:||June 2016 (Final data collection date for primary outcome measure)|
The purpose of the Alzheimer's Disease Genetics Study is to help identify the genes that may be responsible for causing Alzheimer's Disease (AD) by collecting genetic material from families with multiple members diagnosed with AD. Qualifying families will have two living blood-related individuals who have been diagnosed with or are showing symptoms of AD or dementia. Local study sites are located all over the United States, and arrangements may be made for eligible families who do not live near a participating site. The biological samples and data from these families will be made available to qualified researchers, who must sign a Materials Transfer Agreement (MTA) in order to protect the privacy rights of study participants before receiving DNA and data.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00064870
|Contact: Study Coordinatoremail@example.com|
|United States, Indiana|
|Participants are being recruited from all over the United States||Recruiting|
|Nationwide, Indiana, United States, 46202|
|Contact: NCRAD Study Coordinator 800-526-2839 firstname.lastname@example.org|
|Principal Investigator:||Tatiana M. Foroud, PhD||National Cell Repository for Alzheimer's Disease (NCRAD), Indiana University|